Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Dirk LammertsManaging Director, Digital Health
Dr. Lammerts joined Burrill & Company in 2011 to lead the firm’s digital health investments. Throughout his career, Dr. Lammerts has been driving technology convergence through innovative use of computer technologies and online, mobile, and interactive media in medicine, based on the premise that these technologies are providing a platform to fundamentally improve access to and quality of healthcare worldwide. Dr. Lammerts serves on the boards of AliveCor and BetterDoctor.
Dr. Lammerts has more than 20 years of professional experience in healthcare, life sciences, and high-tech industries. He has a combined medical and computer science background. He holds an M.D. from Duesseldorf University Medical School and trained in Neurology at the University of Cologne Medical Center. He also received Board certification in Medical Computer Science by the German Medical Association. Early in his career, Dr. Lammerts developed computer-based training programs for neurological patients suffering from memory and cognitive deficits. He worked as a senior engagement manager for McKinsey & Company advising clients across a broad spectrum of industries in the U.S., Europe, and Asia-Pacific. He has also held positions as Vice President Molecular Diagnostics at Affymetrix and as Vice President Marketing and Corporate Development at XDx, building businesses in molecular diagnostics and personalized medicine.